Spoken Alpha
LH
LABCORP HOLDINGS INC.
Overview
Labcorp provides clinical laboratory testing and drug development services to physicians, hospitals, health systems, pharmaceutical companies, and patients.
LABCORP HOLDINGS INC is a Healthcare company operating in Diagnostics & Research with a $20.88B market cap.
Most recent reported earnings: Q2 FY2026 (Jul 22, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-04-3010 Q&A exchanges
- Q4 FY2025Earnings2026-02-1720 Q&A exchanges
- Q3 FY2025Earnings2025-10-2813 Q&A exchanges
- Q2 FY2025Earnings2025-07-2413 Q&A exchanges
- Q1 FY2025Earnings2025-04-2933 Q&A exchanges
- Q4 FY2024Earnings2025-02-0618 Q&A exchanges
- Q3 FY2024Earnings2024-10-2442 Q&A exchanges
- Q2 FY2024Earnings2024-08-0122 Q&A exchanges
- Q1 FY2024Earnings2024-04-2526 Q&A exchanges
- Q4 FY2023Earnings2024-02-1522 Q&A exchanges
- Q3 FY2023Earnings2023-10-2628 Q&A exchanges
- Q2 FY2023Earnings2023-07-2729 Q&A exchanges
- Q1 FY2023Earnings2023-04-2530 Q&A exchanges
- Q4 FY2022Earnings2023-02-1610 Q&A exchanges
- Q3 FY2022Earnings2022-10-2712 Q&A exchanges
- Q2 FY2022Earnings2022-07-2811 Q&A exchanges
- Q1 FY2022Earnings2022-04-2811 Q&A exchanges
- Q4 FY2021Earnings2022-02-1016 Q&A exchanges
- Q3 FY2021Earnings2021-10-2826 Q&A exchanges
- Q2 FY2021Earnings2021-07-2919 Q&A exchanges
- Q1 FY2021Earnings2021-04-2917 Q&A exchanges
History
Earnings history
- Q2 FY20262026-07-22EPS— vs $4.78—Rev— vs ——EODHD
- Q1 FY20262026-04-29EPS$4.25 vs $4.12+3.3%Rev$3.54B vs ——EODHD
- Q4 FY20252026-02-04EPS$4.07 vs $3.94+3.3%Rev$3.52B vs ——EODHD
- Q3 FY20252025-10-22EPS$4.18 vs $4.11+1.7%Rev$3.56B vs ——EODHD
- Q2 FY20252025-07-23EPS$4.35 vs $4.16+4.6%Rev$3.53B vs ——EODHD
- Q1 FY20252025-04-28EPS$3.84 vs $3.73+2.9%Rev$3.35B vs ——EODHD
- Q4 FY20242025-02-05EPS$3.45 vs $3.39+1.8%Rev$3.33B vs ——EODHD
- Q3 FY20242024-10-23EPS$3.50 vs $3.49+0.3%Rev$3.28B vs ——EODHD
- Q2 FY20242024-07-24EPS$3.94 vs $3.80+3.7%Rev$3.22B vs ——EODHD
- Q1 FY20242024-04-24EPS$3.68 vs $3.48+5.8%Rev$3.18B vs ——EODHD
- Q4 FY20232024-02-14EPS$3.30 vs $3.26+1.2%Rev$3.03B vs ——EODHD
- Q3 FY20232023-10-25EPS$3.38 vs $3.33+1.5%Rev$3.06B vs ——EODHD
- Q2 FY20232023-07-26EPS$3.80 vs $3.53+7.6%Rev$3.03B vs ——EODHD
- Q1 FY20232023-04-24EPS$3.82 vs $3.96-3.5%Rev$3.04B vs ——EODHD
- Q4 FY20222023-02-15EPS$4.14 vs $4.10+1.0%Rev$3.67B vs ——EODHD
- Q3 FY20222022-10-26EPS$4.68 vs $4.67+0.2%Rev$2.87B vs ——EODHD
- Q2 FY20222022-07-27EPS$4.95 vs $4.70+5.3%Rev$2.92B vs ——EODHD
- Q1 FY20222022-04-27EPS$6.11 vs $5.98+2.2%Rev$3.90B vs ——EODHD
- Q4 FY20212022-02-09EPS$6.77 vs $5.80+16.7%Rev$4.06B vs ——EODHD
- Q3 FY20212021-10-27EPS$6.82 vs $4.92+38.6%Rev$4.06B vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-07-22 | — | $4.78 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-04-29 | $4.25 | $4.12 | +3.3% | $3.54B | — | — | EODHD |
| Q4 FY2025 | 2026-02-04 | $4.07 | $3.94 | +3.3% | $3.52B | — | — | EODHD |
| Q3 FY2025 | 2025-10-22 | $4.18 | $4.11 | +1.7% | $3.56B | — | — | EODHD |
| Q2 FY2025 | 2025-07-23 | $4.35 | $4.16 | +4.6% | $3.53B | — | — | EODHD |
| Q1 FY2025 | 2025-04-28 | $3.84 | $3.73 | +2.9% | $3.35B | — | — | EODHD |
| Q4 FY2024 | 2025-02-05 | $3.45 | $3.39 | +1.8% | $3.33B | — | — | EODHD |
| Q3 FY2024 | 2024-10-23 | $3.50 | $3.49 | +0.3% | $3.28B | — | — | EODHD |
| Q2 FY2024 | 2024-07-24 | $3.94 | $3.80 | +3.7% | $3.22B | — | — | EODHD |
| Q1 FY2024 | 2024-04-24 | $3.68 | $3.48 | +5.8% | $3.18B | — | — | EODHD |
| Q4 FY2023 | 2024-02-14 | $3.30 | $3.26 | +1.2% | $3.03B | — | — | EODHD |
| Q3 FY2023 | 2023-10-25 | $3.38 | $3.33 | +1.5% | $3.06B | — | — | EODHD |
| Q2 FY2023 | 2023-07-26 | $3.80 | $3.53 | +7.6% | $3.03B | — | — | EODHD |
| Q1 FY2023 | 2023-04-24 | $3.82 | $3.96 | -3.5% | $3.04B | — | — | EODHD |
| Q4 FY2022 | 2023-02-15 | $4.14 | $4.10 | +1.0% | $3.67B | — | — | EODHD |
| Q3 FY2022 | 2022-10-26 | $4.68 | $4.67 | +0.2% | $2.87B | — | — | EODHD |
| Q2 FY2022 | 2022-07-27 | $4.95 | $4.70 | +5.3% | $2.92B | — | — | EODHD |
| Q1 FY2022 | 2022-04-27 | $6.11 | $5.98 | +2.2% | $3.90B | — | — | EODHD |
| Q4 FY2021 | 2022-02-09 | $6.77 | $5.80 | +16.7% | $4.06B | — | — | EODHD |
| Q3 FY2021 | 2021-10-27 | $6.82 | $4.92 | +38.6% | $4.06B | — | — | EODHD |
Source: EODHD. LH reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks LH's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 60% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.12 | $2.61 | +19.5% | -2.2% | -0.3% |
| Q4 FY2026 | $3.05 | $2.74 | +11.4% | +1.5% | +3.2% |
| Q3 FY2026 | $2.98 | $2.62 | +13.7% | +4.1% | +5.7% |
| Q2 FY2026 | $3.35 | $2.74 | +22.3% | +4.6% | +6.0% |
| Q1 FY2025 | $3.06 | $2.60 | +17.6% | -1.5% | +0.2% |
| Q4 FY2025 | $3.38 | $2.70 | +25.0% | +8.2% | +10.3% |
| Q3 FY2025 | $3.28 | $2.64 | +24.2% | -2.5% | -4.5% |
| Q2 FY2025 | $3.12 | $2.81 | +10.9% | +7.7% | +5.7% |
| Q1 FY2024 | $3.46 | $2.75 | +26.0% | -0.7% | -1.5% |
| Q4 FY2024 | $3.07 | $2.76 | +11.1% | +2.8% | +4.5% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Adam H SchechterCEO4 mo21 callsCurrentSample
CEO since 2026 • 1/2 beats (50%) • last call held guidance Q3 FY2026
- Julia Aijun WangCFO4 mono recorded callsCurrentSample
CFO since 2026 • 1/2 beats (50%) • last guidance cut Q2 FY2026
- Mark S SchroederCOO4 mono recorded callsCurrentSample
COO since 2026 • 1/2 beats (50%) • guidance suspended Q3 FY2026
- Anita Z GrahamEVP, CHRO4 mono recorded callsCurrentSample
OTHER_C_SUITE since 2026 • 1/2 beats (50%) • last guidance cut Q2 FY2026
- Brian J CaveneyEVP, Pres of ED, CMO & CSO4 mono recorded callsCurrentSample
OTHER_C_SUITE since 2026 • 1/2 beats (50%) • last guidance cut Q1 FY2026
- Peter J WilkinsonSVP, Chief Accounting Officer4 mono recorded callsCurrentSample
OTHER_C_SUITE since 2026 • 1/2 beats (50%) • last guidance raise Q2 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for LH.
$ curl https://api.spokenalpha.com/v1/companies/LHFAQ
Frequently asked about LH
Where can I find LABCORP HOLDINGS INC.'s (LH) earnings call transcripts?
Spoken Alpha indexes LH's earnings call transcripts at https://spokenalpha.com/companies/LH. Each call links to attributed speakers and parsed analyst Q&A.
When was LABCORP HOLDINGS INC.'s most recent earnings call?
LABCORP HOLDINGS INC. (LH) held its most recent earnings call on 2026-04-30, covering fiscal Q1 2026.
What sector is LH in?
LABCORP HOLDINGS INC. (LH) operates in the Healthcare sector (Diagnostics & Research industry).